Cladosporium Mold Allergy: Most Abundant, Less Potent Than Alternaria

Cladosporium is the most frequently occurring fungal genus in outdoor air worldwide, with over 772 recognized species. Its ecological success stems from exceptional biological adaptability: it is psychrophilic (grows at temperatures as low as −6 to −10°C), xerophilic (tolerates low water activity of 0.86–0.88), and produces abundant small conidia (3–5 µm) that disperse readily by wind. These traits allow Cladosporium to colonize virtually any plant surface, decaying organic matter, or damp indoor substrate across all four seasons in temperate climates. Summer counts regularly reach 15,000–50,000 spores per cubic meter. Despite being the most abundant mold in outdoor air, it is roughly 30 times less potent per spore than Alternaria in triggering symptoms — the abundance-versus-potency paradox that defines Cladosporium's clinical position.

Cladosporium is far more abundant than Alternaria in outdoor air (counts reaching 50,000 vs 7,500 spores/m³ at peak), but Alternaria is 30 times more potent per spore. Alternaria triggers symptoms at 100 spores/m³; Cladosporium requires 3,000 spores/m³. More critically, Alternaria has the strongest association with severe asthma of any outdoor allergen — an adjusted odds ratio of 189.5 for asthma-related respiratory arrest — while Cladosporium does not carry comparable standalone severe asthma risk. However, co-sensitization with both Alternaria and Cladosporium produces an OR of 63.97 for thunderstorm asthma — dramatically amplified risk beyond either allergen alone. Alternaria also has robust immunotherapy evidence (multiple DBPC-RCTs); Cladosporium AIT is not recommended.

Cladosporium counts peak in the early to mid-afternoon — roughly noon to 5 PM — and are lowest in the early morning hours. This diurnal pattern reflects the mold's response to warm, dry, windy afternoon conditions that favor spore dispersal from outdoor vegetation and soil. Practical implications: scheduling outdoor exercise, gardening, and recreational activities for before 10 AM can reduce daily inhaled allergen dose by 50–70% compared to afternoon activities without changing the activity itself. Monitoring local mold count reports (AAAAI's National Allergy Bureau provides certified counts during allergy season) helps sensitized patients identify particularly high-count days when afternoon outdoor avoidance is most important.

Cladosporium has the lowest SPT-to-sIgE concordance of any major mold allergen — sometimes as low as 30%. This means that testing positive on skin prick predicts a positive blood IgE result in only about 30% of cases, and vice versa — far below the expected concordance for other allergens. The primary reasons are the poor standardization of non-commercial Cladosporium extracts (variability in allergen content between batches makes both tests less consistent) and the cross-reactivity with Alternaria, which can cause apparent Cladosporium positivity via cross-reactive IgE that tests differently in different assay formats. The clinical consequence: both test modalities should be obtained in patients with suspected Cladosporium sensitization, and a negative result on either test does not definitively exclude sensitization.

Allergen immunotherapy is NOT recommended for Cladosporium sensitization by international guidelines (AAAAI, EAACI, WAO). Only one early controlled trial exists (Dreborg 1986, 16 children), and meta-analysis of standard mold panels subsequently identified Cladosporium extract as responsible for the majority of systemic side effects seen with mold immunotherapy — raising safety concerns that have never been resolved with controlled trials. This distinguishes Cladosporium from Alternaria, where multiple DBPC-RCTs validate SCIT and SLIT. For patients testing positive to Cladosporium, component testing (rCla h 8, rAlt a 1) should be pursued: if primary Alternaria sensitization is confirmed via cross-reactivity, Alternaria-targeted immunotherapy with strong evidence becomes appropriate. If primary Cladosporium sensitization is confirmed, management remains pharmacological.

Yes — Cladosporium is among the top three most common indoor airborne fungi and colonizes damp building surfaces as a secondary indoor mold. Common indoor sites include windowsills with condensation, bathroom grout, damp basement materials, and carpets in areas with persistent humidity. Unlike primary water-damage indicator molds (Stachybotrys requires water activity ≥0.94), Cladosporium's xerophilicity (tolerates aw 0.86–0.88) means it can colonize surfaces that are only moderately damp rather than chronically wet. Standard indoor mold prevention applies: maintain humidity 30–50%, fix water leaks within 24–48 hours, ensure bathroom ventilation, and address any visible mold growth on non-porous surfaces with appropriate cleaning.

Cla h 8 (NADP-dependent mannitol dehydrogenase, 29.5 kDa) is the dominant major allergen of Cladosporium herbarum and the only Cladosporium molecular allergen commercially available for component-resolved diagnostics. It is recognized by 57% of Cladosporium-sensitized patients — the highest IgE reactivity of any Cladosporium protein. Its clinical importance extends beyond diagnosis: Cla h 8 shares 85.7% amino acid sequence identity with Alt a 8 (Alternaria mannitol dehydrogenase), creating cross-reactive IgE that can make Cladosporium appear positive in patients who are primarily Alternaria-sensitized. Testing rCla h 8 alongside rAlt a 1 resolves this ambiguity — a genuinely Cladosporium-sensitized patient will be rCla h 8-positive, whereas a primarily Alternaria-sensitized patient with cross-reactive IgE may be rAlt a 1-positive with only weakly cross-reactive rCla h 8.

Cladosporium co-sensitization dramatically amplifies thunderstorm asthma risk in patients already sensitized to Alternaria. A 2000 Cambridge UK thunderstorm asthma event quantified this precisely: Alternaria-sensitized patients had an OR of 9.31 for thunderstorm asthma, while those co-sensitized with both Alternaria and Cladosporium had an OR of 63.97 — a 7-fold amplification of an already elevated risk. The mechanism involves thunderstorm outflows fragmenting Cladosporium spores (like Alternaria) into respirable sub-particles carrying intact allergen, with the combined allergen dose from both species overwhelming the sensitized airway simultaneously. Patients with dual mold sensitization should treat every summer afternoon thunderstorm as a potential trigger: close windows immediately, take pre-treatment doses of antihistamines, and stay indoors with the rescue inhaler at hand.

IgE-mediated Cladosporium allergy primarily causes respiratory and ocular symptoms rather than skin rashes. Urticaria (hives) is a possible but uncommon manifestation in highly sensitized individuals with intense direct skin exposure to concentrated mold during activities like gardening or composting in high-count areas. Contact dermatitis from Cladosporium is not a well-documented entity. If you experience consistent skin reactions after outdoor mold exposure, discuss the symptom pattern with your allergist — patch testing and skin prick testing together can help distinguish IgE-mediated skin reactivity from irritant contact reactions. Unexplained urticaria or angioedema should always be evaluated by an allergist regardless of suspected trigger.